741 related articles for article (PubMed ID: 16461184)
1. Role of aldosterone in left ventricular hypertrophy in hypertension.
Matsumura K; Fujii K; Oniki H; Oka M; Iida M
Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
[TBL] [Abstract][Full Text] [Related]
2. Cardiac consequences of aldosterone excess in human hypertension.
Rossi GP
Am J Hypertens; 2006 Jan; 19(1):10-2. PubMed ID: 16461183
[No Abstract] [Full Text] [Related]
3. Effects of angiotensin-converting enzyme gene polymorphism and serum vitamin D levels on ambulatory blood pressure measurement and left ventricular mass in Turkish hypertensive population.
Kulah E; Dursun A; Aktunc E; Acikgoz S; Aydin M; Can M; Dursun A
Blood Press Monit; 2007 Aug; 12(4):207-13. PubMed ID: 17625392
[TBL] [Abstract][Full Text] [Related]
4. Twenty-four-hour heart rate and blood pressure are additive markers of left ventricular mass in hypertensive subjects.
Zakopoulos NA; Ikonomidis I; Vemmos KN; Manios E; Spiliopoulou I; Tsivgoulis G; Spengos K; Psaltopoulou D; Mavrikakis M; Moulopoulos SD
Am J Hypertens; 2006 Feb; 19(2):170-7. PubMed ID: 16448887
[TBL] [Abstract][Full Text] [Related]
5. Prevalent influence of systolic over pulse pressure on left ventricular mass in essential hypertension.
Verdecchia P; Schillaci G; Borgioni C; Gattobigio R; Ambrosio G; Porcellati C
Eur Heart J; 2002 Apr; 23(8):658-65. PubMed ID: 11969281
[TBL] [Abstract][Full Text] [Related]
6. Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension.
Shigematsu Y; Hamada M; Mukai M; Matsuoka H; Sumimoto T; Hiwada K
J Hypertens; 1995 Jan; 13(1):155-60. PubMed ID: 7759846
[TBL] [Abstract][Full Text] [Related]
7. [Association between blood pressure and circulating hormonal factors with left ventricular mass in patients with essential hypertension older than 55 years of age].
González Quijada S; Luque Otero M; Fernández-Cruz A; Almería C; Bagazgoitia Barrera J; Moya Marín FJ
Med Clin (Barc); 1997 Oct; 109(12):441-4. PubMed ID: 9441177
[TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetes is associated with left ventricular concentric remodeling in hypertensive patients.
Eguchi K; Kario K; Hoshide S; Ishikawa J; Morinari M; Shimada K
Am J Hypertens; 2005 Jan; 18(1):23-9. PubMed ID: 15691613
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure.
Jacobi J; Schlaich MP; Delles C; Schobel HP; Schmieder RE
Am J Hypertens; 1999 Apr; 12(4 Pt 1):418-22. PubMed ID: 10232503
[TBL] [Abstract][Full Text] [Related]
10. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension.
Stergiou GS; Argyraki KK; Moyssakis I; Mastorantonakis SE; Achimastos AD; Karamanos VG; Roussias LG
Am J Hypertens; 2007 Jun; 20(6):616-21. PubMed ID: 17531917
[TBL] [Abstract][Full Text] [Related]
11. [Relation between left ventricular hypertrophy and retinal vascular changes in mild hypertension].
Pose Reino A; González-Juanatey JR; Castroviejo M; Valdés L; Estévez JC; Méndez I; Cabezas-Cerrato J
Med Clin (Barc); 1997 Mar; 108(8):281-5. PubMed ID: 9121203
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular anatomy and function in primary aldosteronism and renovascular hypertension.
Pessina AC; Sacchetto A; Rossi GP
Adv Exp Med Biol; 1997; 432():63-9. PubMed ID: 9433512
[TBL] [Abstract][Full Text] [Related]
13. Cardiac hypertrophy in hypertension: relation to 24-h blood pressure profile and arterial stiffness.
Lekakis JP; Zakopoulos NA; Protogerou AD; Kotsis VT; Papaioannou TG; Stamatelopoulos KS; Tsitsiricos MD; Pitiriga VCh; Papamichael CM; Toumanides ST; Mavrikakis ME
Int J Cardiol; 2004 Oct; 97(1):29-33. PubMed ID: 15336803
[TBL] [Abstract][Full Text] [Related]
14. Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension.
Pouleur AC; Uno H; Prescott MF; Desai A; Appelbaum E; Lukashevich V; Smith BA; Dahlöf B; Solomon SD;
J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):483-90. PubMed ID: 21746765
[TBL] [Abstract][Full Text] [Related]
15. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A
Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
[TBL] [Abstract][Full Text] [Related]
16. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
Rakić D; Rumboldt Z; Bagatin J; Polić S
Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
[TBL] [Abstract][Full Text] [Related]
17. Arterial hypertension, left ventricular geometry and QT dispersion in a middle-aged Estonian female population.
Shipilova T; Pshenichnikov I; Kaik J; Volozh O; Abina J; Kalev M; Lass J; Karai D
Blood Press; 2003; 12(1):12-8. PubMed ID: 12699130
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases.
Médeau V; Moreau F; Trinquart L; Clemessy M; Wémeau JL; Vantyghem MC; Plouin PF; Reznik Y
Clin Endocrinol (Oxf); 2008 Jul; 69(1):20-8. PubMed ID: 18284637
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
[TBL] [Abstract][Full Text] [Related]
20. Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels.
Catena C; Colussi G; Valeri M; Sechi LA
Am J Hypertens; 2013 Jan; 26(1):111-7. PubMed ID: 23382334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
